Eb, thanks for the updates ...greatly appreciated. I wonder how Eli Lilly is doing with Loxo Oncology as they are only the 2nd behind Merck for FDA approval based upon tissue etc not location of tumor
Lots of PS Targeting research involved as CGI Cancer Genetics Inc ( that aided Keytruda) has ties in Loxo
Cancer Genetics Inc and HTG Molecular deal as CGI scooped up by Interpace Diagnostics ...which was scooped up by Ampersand
Ampersand was brought in for Avid CDMO as Biomarkers were KEY...much more interest from new IIS that will not settle